Welcome to PsychU!

Revisiting Cognitive Deficits In Bipolar Disorder

Neurocognitive deficits are commonly experienced by individuals living with bipolar disorder. Bipolar disorder is known to affect attention, processing speed, verbal learning and memory, and executive functions, including working memory… Read More

Webinar Summary – Gender Differences In Depression

This summary was developed utilizing the full recorded presentation of this webinar. You can access the full sourcing, polling results, recording, or presentation slides here: https://psychu.org/gender-differences-in-depression/. On March 7, 2019,… Read More

Neuromodulation Techniques: State Of The Science

Clinicians managing patients with behavioral health issues are presented with various diagnostic and treatment challenges, spanning the areas of neurobiology, adherence, safety, and medication tolerability. Currently available pharmacotherapeutic, psychotherapeutic, and… Read More

Neurobiology Of Risk For Bipolar Disorder

Key Messages Tools that would facilitate early diagnosis, intervention, and prevention of new bipolar episodes may be of benefit to patients with bipolar disorder or who may develop bipolar disorder… Read More

Immunology Of Major Depression

Key Messages Evidence has indicated that the inflammatory system may play a key role in major depression (MD). Characteristics of immune activation have been observed in MD, and several cytokines… Read More

Inflammation In Neurological & Psychiatric Diseases

Key Messages This review article examined findings on the relationship of inflammation with neurological and psychiatric disorders. Several lines of evidence supported the role of inflammation in the pathophysiology of… Read More

Depression, Serotonin & Tryptophan

Key Messages Research into the pathophysiology of depression has moved beyond the serotonergic system to examine the interplay of wider body systems and processes. This article reviewed recent literature pertaining… Read More

The Neurobiology Of Relapse In Schizophrenia

Key Messages Relapse rates among patients with first-episode schizophrenia have been reported to exceed 80% within 5 years. This review of the neurophysiology of schizophrenia relapse suggests that dopamine may… Read More